全球 DNA 合成市場規模、佔有率、成長分析（按服務類型、按應用、按最終用戶）- 產業預測，2023-2030 年

2022年全球DNA合成市場規模為29億美元，從2023年的34.6億美元成長到2031年的145.3億美元，預測期內（2024-2031年）複合年成長率為19.63%。

由於其在製藥、生物技術和遺傳學研究等各個領域的重要作用，全球 DNA 合成市場正在顯著成長。研究人員和生物技術公司擴大利用 DNA 合成服務來創建 DNA 序列，用於從藥物開發到基因工程的廣泛應用。對合成生物學工具不斷成長的需求、個人化醫療的出現以及基因編輯技術的進步推動了這個市場的擴張。此外，DNA 合成服務有助於實驗室中的快速原型製作和實驗，促進創新並加快科學突破的步伐。隨著生物技術和醫療領域的不斷發展，DNA 合成市場有望對基因組學和分子生物學的發展軌跡產生重大影響。

目錄

執行摘要

• 市場概況
• 轉型

調查方法

• 資訊採購
• 次要和主要資料來源
• 市場規模估算
• 市場假設與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 監管環境
• 波特的分析
• 對未來中斷的特殊考慮

全球 DNA 合成市場：依服務類型

• 市場概況
• 基因合成
• 寡核苷酸合成

DNA 合成的全球市場：依應用分類

• 市場概況
• 研究與開發
• 治療

全球 DNA 合成市場：依最終用戶分類

• 市場概況
• 生物製藥公司
• 學術研究所
• 受託研究機構

全球 DNA 合成市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2021年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2021年）

主要企業簡介

• 賽默飛世爾科技公司（美國）
• Twist Bioscience（美國）
• Bioneer 公司（韓國）
• 伊頓生物科學（美國）
• LGC Biosearch Technologies（美國）
• IBA 有限公司（德國）
• Eurofins Scientific（盧森堡）
• Integrated DNA Technologies, Inc.（美國）
• Quintara Biosciences（美國）
• 金斯瑞生物科技股份有限公司 (中國)
• 安捷倫科技（美國）
• 默克公司（德國）
• 歐根泰克（比利時）
• Cambio 有限公司（英國）
• Biomatik（加拿大）

Global DNA Synthesis Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.46 Billion in 2023 to USD 14.53 Billion by 2031, at a CAGR of 19.63% during the forecast period (2024-2031).

The global DNA synthesis market is witnessing notable growth owing to its crucial role across various sectors including pharmaceuticals, biotechnology, and genetics research. Researchers and biotech firms are increasingly turning to DNA synthesis services to create tailored DNA sequences for a broad array of applications, spanning from drug development to genetic manipulation. This market's expansion is fuelled by the escalating demand for synthetic biology tools, the emergence of personalized medicine, and the ongoing advancements in gene editing technologies. Furthermore, DNA synthesis services facilitate swift prototyping and experimentation in laboratories, fostering innovation and expediting the pace of scientific breakthroughs. As the biotechnology and healthcare sectors continue to progress, the DNA synthesis market stands ready to exert significant influence on the trajectory of genomics and molecular biology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global DNA Synthesis and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global DNA Synthesis Market Segmental Analysis

The global DNA synthesis market is segmented on the basis of Service type, Application, End-user, and region. Based on service type the market is segmented as Gene Synthesis, Oligonucleotide Synthesis. On the basis of application, the market is segmented as Research and Development, Therapeutics. Based on end-user, it is segregated into Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global DNA Synthesis Market

One of the primary factors propelling the DNA synthesis market is the ongoing progress in genetic engineering technologies. Breakthroughs such as CRISPR-Cas9 and other gene-editing methods have notably heightened the need for customized DNA sequences, thereby stimulating the expansion of DNA synthesis services. Given the necessity for precise and tailored DNA constructs in their endeavours, researchers and biotech firms consider DNA synthesis an indispensable element of advanced genetic engineering initiatives.

Restraints in the Global DNA Synthesis Market

A significant challenge in the DNA synthesis sector is the strict regulatory landscape. Rigorous regulations and supervision concerning the synthesis and application of genetic materials, particularly in gene editing and biotechnology, can erect obstacles to entering the market and impede research and development endeavours. While these regulations are crucial for ethical and safety considerations, they can present hurdles for businesses operating in this domain.

Market Trends of the Global DNA Synthesis Market

A significant trend in the DNA synthesis sector is the ongoing progress in gene editing technologies, exemplified by CRISPR-Cas9. These advancements are spurring the need for customized DNA sequences, facilitating precise genetic alterations across various domains like therapeutic research and agriculture. With gene editing tools becoming increasingly accessible and adaptable, the DNA synthesis market is positioned for continuous expansion, meeting the changing demands of researchers and biotech entities.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global DNA Synthesis Market by Service Type

• Market Overview
• Gene Synthesis
• Oligonucleotide Synthesis

Global DNA Synthesis Market by Application

• Market Overview
• Research And Development
• Therapeutics

Global DNA Synthesis Market by End-user

• Market Overview
• Biopharmaceutical Companies
• Academic and Research Institutes
• Contract Research Organizations

Global DNA Synthesis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eton Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quintara Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurogentec (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambio Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomatik (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments